Patent Application
Provisional
App. No. 63/383,132
· Confirmation No. 2829
USES OF EP2/EP4 ANTAGONIST COMPOUNDS FOR TREATING FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Applicant:
Tempest Therapeutics, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-06-12 | R48.REQ.G |
Acceptance of Request under Rule 48 to correct inventorship or name | 1 | View | |
| 2023-06-12 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2023-06-07 | CFILE |
Request for Corrected Filing Receipt | 1 | View | |
| 2023-06-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-06-07 | ADS |
Application Data Sheet | 8 | View | |
| 2023-06-07 | R48.REQ |
Request under Rule 48 correcting inventorship | 3 | View | |
| 2023-06-07 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2022-11-17 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-11-10 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2022-11-10 | SPEC |
Specification | — | View | |
| 2022-11-10 | SPEC |
Specification | 32 | View | |
| 2022-11-10 | CLM |
Claims | 2 | View | |
| 2022-11-10 | ABST |
Abstract | 1 | View | |
| 2022-11-10 | DRW.NONBW |
Drawings-other than black and white line drawings | 14 | View | |
| 2022-11-10 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-11-10 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2022-11-10 | ADS |
Application Data Sheet | 8 | View | |
| 2022-11-10 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Brian FRANCICA
El Cerrito, CA
Sam H. WHITING
Seattle, WA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 21971
- Docket No.
- 53238-739.101
- Confirmation No.
- 2829
from
OXFORD FINANCE LLC
RELEASE OF SECURITY INTEREST
Recorded 2025-04-10
from
FRANCICA, BRIAN
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-06-27
from
WHITING, SAM H.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-06-27
from
MILLENDO THERAPEUTICS US, INC.,
TEMPEST THERAPEUTICS, INC. (F/K/A MILLENDO THERAPEUTICS, INC.),
TEMPESTTX, INC. (F/K/A TEMPEST THERAPEUTICS, INC.)
SECURITY INTEREST
Recorded 2022-12-28
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/383,132
- Filed
- 2022-11-10
External Links